Newsweek's No. 1 hospital in Southern Malaysia for 2 consecutive years, Ranked for cancer care, cardiac surgery, and 47 specialties
Mahkota Medical Centre in Melaka has built its reputation through specific clinical achievements that most hospitals in Southeast Asia have not reached: the world's only JCI-certified Chronic Kidney Disease programme, Malaysia's first JCI-certified Breast Cancer Clinical Care Programme, and Southeast Asia's first Tomotherapy Radixact X7 radiotherapy system.
Every year, international patients from 10+ countries choose Mahkota for treatment - from Indonesia, Singapore, Bangladesh, Cambodia, Brunei, and beyond.
They come because of the clinical outcomes, but many stay because of what surrounds them: 19 authorised representative offices across the region, coordinators who speak Bahasa Indonesia, Mandarin, and English, free airport transfers, and a system designed so that from your first enquiry, your entire journey is mapped out before you board a flight.
Melaka is an easy choice logistically as well as clinically. The city sits 1.5 hours from Kuala Lumpur International Airport and is accessible from Singapore by road in under 3 hours. In 32 years of treating patients from across Asia, Mahkota has performed 2,000+ orthopaedic surgeries annually, 8,500+ cardiac procedures over five years. These are not aspirational targets. They are what patients experience when they arrive.
Looking for a specific insurance provider? Simply use our search function or contact us for assistance and our knowledgeable team will happily verify whether your provider is accepted at our facility.
Ask about your insurance
Appointments, report reviews, cost estimates, and travel coordination at Mahkota Medical Centre are arranged through the International Patient Care team.
The team arranges video consultations, in-person appointments, second medical opinions, and full treatment coordination.
Support is available in English, Bahasa Indonesia, and Mandarin through the team and affiliated representative offices.
Yes. Mahkota Medical Centre is ranked No. 1 hospital in Southern Malaysia by Newsweek and Statista in both 2024 and 2025, with specific recognition in Oncology, Cardiology, and Endocrinology.
Key reasons behind the ranking:
Yes. Mahkota is JCI-accredited through 2026, the international gold standard for hospital quality and patient safety.
It also holds 2 additional JCI Clinical Care Programme Certifications — for Breast Cancer (first in Malaysia) and Chronic Kidney Disease (world's only). Full MSQH and ISO 15189 laboratory accreditation are also in place.
More than 95,000 international patients receive care at Mahkota every year.
Treatment in Malaysia at Mahkota costs significantly less than the UK, US, Germany, Australia, and Singapore. Savings of 60 to 70% are common on major procedures.
Verified cost comparisons:
Personalised written estimates are available from the international patient team before any financial commitment is required.
Mahkota Medical Centre is located in Melaka town centre, a UNESCO World Heritage city in Southern Peninsular Malaysia.
Getting here:
All transfers are arranged in advance by the international patient team at no additional cost.